A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From CHERISH

MLA

Daniel J. Lovell, et al. “A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From CHERISH.” Arthritis & Rheumatology, vol. 66, Mar. 2014, pp. S5–6. EBSCOhost, https://doi.org/10.1002/art.38415.

APA

Daniel J. Lovell, Jianmei Wang, Ricardo Machado Xavier, Kamal N. Bharucha, Hermine I. Brunner, Ruben Cuttica, Zbigniew Zuber, Nadina Rubio, Vyacheslav Chasnyk, C. Keane, Jose Chavez, Alberto Spindler, Alberto Martini, Fabrizio De Benedetti, Inmaculada Calvo, Pierre Quartier, Nicolino Ruperto, Violetta Opoka-Winiarska, Ekaterina Alekseeva, & Gerd Horneff. (2014). A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From CHERISH. Arthritis & Rheumatology, 66, S5–S6. https://doi.org/10.1002/art.38415

Chicago

Daniel J. Lovell, Jianmei Wang, Ricardo Machado Xavier, Kamal N. Bharucha, Hermine I. Brunner, Ruben Cuttica, Zbigniew Zuber, et al. 2014. “A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From CHERISH.” Arthritis & Rheumatology 66 (March): S5–6. doi:10.1002/art.38415.